Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Fast Track Articles
  5. Fast Track Article
image of Homocysteine Blood Levels and Mandatory Folic Acid Fortification in Serbia

Abstract

Introduction/Objective

The current study aims to investigate the blood Hcy levels in patients with CAD and hypertension in Serbia, a country with a high incidence and mortality of both diseases.

Methods

The level of Hcy in the Serbian population was assessed in 123 patients with chronic coronary artery disease (CAD) and hypertension. There were 53 patients with chronic CAD and 70 patients with hypertension (HTA), but without CAD.

Results

The Hcy levels were high in both groups of patients (the mean Hcy level of 16.0 ± 7.0 µmol/L) without a statistical difference between the patients in the CAD (14.9 ± 7.3 µmol/L) and hypertension (16.7 ± 6.7 µmol/L) groups. Hypercholesterolemia was found in 81% of the patients with CAD and 92.0% of the patients with HTA, as a common concern across both clinical conditions. It was also found that not a single conventional risk factor (diabetes, hypertension, the smoking status, the family history of CAD, and hyperlipidemia) may individually influence Hcy levels. By contrast, the low levels of vitamin B12 may be related to the high levels of Hcy.

Conclusion

Given the fact that it is known that various factors interact and influence Hcy levels and associated cardiovascular risks, specific dietary habits, lifestyle and the other Serbia-specific possible factors were done.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128326875240916050251
2024-10-03
2024-12-03

  • From This Site

    /content/journals/cpd/10.2174/0113816128326875240916050251
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Lonn E. Yusuf S. Arnold M.J. Sheridan P. Pogue J. Micks M. McQueen M.J. Probstfield J. Fodor G. Held C. Genest J. Jr Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006 354 15 1567 1577 10.1056/NEJMoa060900 16531613
    [Google Scholar]
  2. Chrysant S.G. Chrysant G.S. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev. Cardiovasc. Ther. 2018 16 8 559 565 10.1080/14779072.2018.1497974 29979619
    [Google Scholar]
  3. Djuric D. Jakovljevic V. Rasic-Markovic A. Djuric A. Stanojlovic O. Homocysteine, folic acid and coronary artery disease: possible impact on prognosis and therapy. Indian J. Chest Dis. Allied Sci. 2008 50 1 39 48 18610689
    [Google Scholar]
  4. Foscolou A. Rallidis L.S. Tsirebolos G. Critselis E. Katsimardos A. Drosatos A. Chrysohoou C. Tousoulis D. Pitsavos C. Panagiotakos D.B. The association between homocysteine levels, Mediterranean diet and cardiovascular disease: a case-control study. Int. J. Food Sci. Nutr. 2019 70 5 603 611 10.1080/09637486.2018.1547688 30501542
    [Google Scholar]
  5. Wald D.S. Law M. Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002 325 7374 1202 1206 10.1136/bmj.325.7374.1202 12446535
    [Google Scholar]
  6. Beletić A. Mirković D. Antonijević N. Đorđević V. Šango V. Jakovljević B. Peruničić J. Ilić M. Vasiljević Z. Majkić-Singh N. Incidence of hypehomocysteinemia and MTHFR C677T Polymorphism among young patients with acute myocardial infarction. J. Med. Biochem. 2009 28 1 41 45 10.2478/v10011‑008‑0029‑9
    [Google Scholar]
  7. Debreceni B. Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc. Ther. 2012 30 4 227 233 10.1111/j.1755‑5922.2011.00266.x 21884001
    [Google Scholar]
  8. Abraham J.M. Cho L. The homocysteine hypothesis: Still relevant to the prevention and treatment of cardiovascular disease? Cleve. Clin. J. Med. 2010 77 12 911 918 10.3949/ccjm.77a.10036 21147945
    [Google Scholar]
  9. Peng H. Man C. Xu J. Fan Y. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies. J. Zhejiang Univ. Sci. B 2015 16 1 78 86 10.1631/jzus.B1400183 25559959
    [Google Scholar]
  10. García-Fernández E. Rico-Cabanas L. Rosgaard N. Estruch R. Bach-Faig A. Mediterranean diet and cardiodiabesity: a review. Nutrients 2014 6 9 3474 3500 10.3390/nu6093474 25192027
    [Google Scholar]
  11. Lewis S.J. Ebrahim S. Smith G.D. Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 2005 331 7524 1053 10.1136/bmj.38611.658947.55 16216822
    [Google Scholar]
  12. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002 288 16 2015 2022 10.1001/jama.288.16.2015 12387654
    [Google Scholar]
  13. Refsum H. Nurk E. David Smith A. Ueland P.M. Gjesdal C.G. Bjelland I. Tverdal A. Tell G.S. Nygård O. Vollset S.E. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 2006 136 6 Suppl. 1731S 1740S 10.1093/jn/136.6.1731S 16702348
    [Google Scholar]
  14. Iso H. Moriyama Y. Sato S. Kitamura A. Tanigawa T. Yamagishi K. Imano H. Ohira T. Okamura T. Naito Y. Shimamoto T. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004 109 22 2766 2772 10.1161/01.CIR.0000131942.77635.2D 15159287
    [Google Scholar]
  15. Menotti A. Puddu P.E. Maiani G. Catasta G. Cardiovascular and other causes of death as a function of lifestyle habits in a quasi extinct middle-aged male population. A 50-year follow-up study. Int. J. Cardiol. 2016 210 173 178 10.1016/j.ijcard.2016.02.115 26962972
    [Google Scholar]
  16. Bostom A.G. Rosenberg I.H. Silbershatz H. Jacques P.F. Selhub J. D’Agostino R.B. Wilson P.W.F. Wolf P.A. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann. Intern. Med. 1999 131 5 352 355 10.7326/0003‑4819‑131‑5‑199909070‑00006 10475888
    [Google Scholar]
  17. Zhang Z. Gu X. Fang X. Tang Z. Guan S. Liu H. Wu X. Wang C. Zhao Y. Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study. Ther. Clin. Risk Manag. 2020 16 471 481 10.2147/TCRM.S239496 32547044
    [Google Scholar]
  18. Bots M.L. Launer L.J. Lindemans J. Hoes A.W. Hofman A. Witteman J.C.M. Koudstaal P.J. Grobbee D.E. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch. Intern. Med. 1999 159 1 38 44 10.1001/archinte.159.1.38 9892328
    [Google Scholar]
  19. Anderson J.L. Muhlestein J.B. Horne B.D. Carlquist J.F. Bair T.L. Madsen T.E. Pearson R.R. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 2000 102 11 1227 1232 10.1161/01.CIR.102.11.1227 10982535
    [Google Scholar]
  20. Barnabé A. Aléssio A.C.M. Bittar L.F. de Moraes Mazetto B. Bicudo A.M. de Paula E.V. Höehr N.F. Annichino-Bizzacchi J.M. Folate, Vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center. Nutr. J. 2015 14 1 19 10.1186/s12937‑015‑0006‑3 25886278
    [Google Scholar]
  21. Roth G.A. Mensah G.A. Johnson C.O. Addolorato G. Ammirati E. Baddour L.M. Barengo N.C. Beaton A.Z. Benjamin E.J. Benziger C.P. Bonny A. Brauer M. Brodmann M. Cahill T.J. Carapetis J. Catapano A.L. Chugh S.S. Cooper L.T. Coresh J. Criqui M. DeCleene N. Eagle K.A. Emmons-Bell S. Feigin V.L. Fernández-Solà J. Fowkes G. Gakidou E. Grundy S.M. He F.J. Howard G. Hu F. Inker L. Karthikeyan G. Kassebaum N. Koroshetz W. Lavie C. Lloyd-Jones D. Lu H.S. Mirijello A. Temesgen A.M. Mokdad A. Moran A.E. Muntner P. Narula J. Neal B. Ntsekhe M. Moraes de Oliveira G. Otto C. Owolabi M. Pratt M. Rajagopalan S. Reitsma M. Ribeiro A.L.P. Rigotti N. Rodgers A. Sable C. Shakil S. Sliwa-Hahnle K. Stark B. Sundström J. Timpel P. Tleyjeh I.M. Valgimigli M. Vos T. Whelton P.K. Yacoub M. Zuhlke L. Murray C. Fuster V. Roth G.A. Mensah G.A. Johnson C.O. Addolorato G. Ammirati E. Baddour L.M. Barengo N.C. Beaton A. Benjamin E.J. Benziger C.P. Bonny A. Brauer M. Brodmann M. Cahill T.J. Carapetis J.R. Catapano A.L. Chugh S. Cooper L.T. Coresh J. Criqui M.H. DeCleene N.K. Eagle K.A. Emmons-Bell S. Feigin V.L. Fernández-Sola J. Fowkes F.G.R. Gakidou E. Grundy S.M. He F.J. Howard G. Hu F. Inker L. Karthikeyan G. Kassebaum N.J. Koroshetz W.J. Lavie C. Lloyd-Jones D. Lu H.S. Mirijello A. Misganaw A.T. Mokdad A.H. Moran A.E. Muntner P. Narula J. Neal B. Ntsekhe M. Oliveira G.M.M. Otto C.M. Owolabi M.O. Pratt M. Rajagopalan S. Reitsma M.B. Ribeiro A.L.P. Rigotti N.A. Rodgers A. Sable C.A. Shakil S.S. Sliwa K. Stark B.A. Sundström J. Timpel P. Tleyjeh I.I. Valgimigli M. Vos T. Whelton P.K. Yacoub M. Zuhlke L.J. Abbasi-Kangevari M. Abdi A. Abedi A. Aboyans V. Abrha W.A. Abu-Gharbieh E. Abushouk A.I. Acharya D. Adair T. Adebayo O.M. Ademi Z. Advani S.M. Afshari K. Afshin A. Agarwal G. Agasthi P. Ahmad S. Ahmadi S. Ahmed M.B. Aji B. Akalu Y. Akande-Sholabi W. Aklilu A. Akunna C.J. Alahdab F. Al-Eyadhy A. Alhabib K.F. Alif S.M. Alipour V. Aljunid S.M. Alla F. Almasi-Hashiani A. Almustanyir S. Al-Raddadi R.M. Amegah A.K. Amini S. Aminorroaya A. Amu H. Amugsi D.A. Ancuceanu R. Anderlini D. Andrei T. Andrei C.L. Ansari-Moghaddam A. Anteneh Z.A. Antonazzo I.C. Antony B. Anwer R. Appiah L.T. Arabloo J. Ärnlöv J. Artanti K.D. Ataro Z. Ausloos M. Avila-Burgos L. Awan A.T. Awoke M.A. Ayele H.T. Ayza M.A. Azari S. B D.B. Baheiraei N. Baig A.A. Bakhtiari A. Banach M. Banik P.C. Baptista E.A. Barboza M.A. Barua L. Basu S. Bedi N. Béjot Y. Bennett D.A. Bensenor I.M. Berman A.E. Bezabih Y.M. Bhagavathula A.S. Bhaskar S. Bhattacharyya K. Bijani A. Bikbov B. Birhanu M.M. Boloor A. Brant L.C. Brenner H. Briko N.I. Butt Z.A. Caetano dos Santos F.L. Cahill L.E. Cahuana-Hurtado L. Cámera L.A. Campos-Nonato I.R. Cantu-Brito C. Car J. Carrero J.J. Carvalho F. Castañeda-Orjuela C.A. Catalá-López F. Cerin E. Charan J. Chattu V.K. Chen S. Chin K.L. Choi J-Y.J. Chu D-T. Chung S-C. Cirillo M. Coffey S. Conti S. Costa V.M. Cundiff D.K. Dadras O. Dagnew B. Dai X. Damasceno A.A.M. Dandona L. Dandona R. Davletov K. De la Cruz-Góngora V. De la Hoz F.P. De Neve J-W. Denova-Gutiérrez E. Derbew Molla M. Derseh B.T. Desai R. Deuschl G. Dharmaratne S.D. Dhimal M. Dhungana R.R. Dianatinasab M. Diaz D. Djalalinia S. Dokova K. Douiri A. Duncan B.B. Duraes A.R. Eagan A.W. Ebtehaj S. Eftekhari A. Eftekharzadeh S. Ekholuenetale M. El Nahas N. Elgendy I.Y. Elhadi M. El-Jaafary S.I. Esteghamati S. Etisso A.E. Eyawo O. Fadhil I. Faraon E.J.A. Faris P.S. Farwati M. Farzadfar F. Fernandes E. Fernandez Prendes C. Ferrara P. Filip I. Fischer F. Flood D. Fukumoto T. Gad M.M. Gaidhane S. Ganji M. Garg J. Gebre A.K. Gebregiorgis B.G. Gebregzabiher K.Z. Gebremeskel G.G. Getacher L. Obsa A.G. Ghajar A. Ghashghaee A. Ghith N. Giampaoli S. Gilani S.A. Gill P.S. Gillum R.F. Glushkova E.V. Gnedovskaya E.V. Golechha M. Gonfa K.B. Goudarzian A.H. Goulart A.C. Guadamuz J.S. Guha A. Guo Y. Gupta R. Hachinski V. Hafezi-Nejad N. Haile T.G. Hamadeh R.R. Hamidi S. Hankey G.J. Hargono A. Hartono R.K. Hashemian M. Hashi A. Hassan S. Hassen H.Y. Havmoeller R.J. Hay S.I. Hayat K. Heidari G. Herteliu C. Holla R. Hosseini M. Hosseinzadeh M. Hostiuc M. Hostiuc S. Househ M. Huang J. Humayun A. Iavicoli I. Ibeneme C.U. Ibitoye S.E. Ilesanmi O.S. Ilic I.M. Ilic M.D. Iqbal U. Irvani S.S.N. Islam S.M.S. Islam R.M. Iso H. Iwagami M. Jain V. Javaheri T. Jayapal S.K. Jayaram S. Jayawardena R. Jeemon P. Jha R.P. Jonas J.B. Jonnagaddala J. Joukar F. Jozwiak J.J. Jürisson M. Kabir A. Kahlon T. Kalani R. Kalhor R. Kamath A. Kamel I. Kandel H. Kandel A. Karch A. Kasa A.S. Katoto P.D.M.C. Kayode G.A. Khader Y.S. Khammarnia M. Khan M.S. Khan M.N. Khan M. Khan E.A. Khatab K. Kibria G.M.A. Kim Y.J. Kim G.R. Kimokoti R.W. Kisa S. Kisa A. Kivimäki M. Kolte D. Koolivand A. Korshunov V.A. Koulmane Laxminarayana S.L. Koyanagi A. Krishan K. Krishnamoorthy V. Kuate Defo B. Kucuk Bicer B. Kulkarni V. Kumar G.A. Kumar N. Kurmi O.P. Kusuma D. Kwan G.F. La Vecchia C. Lacey B. Lallukka T. Lan Q. Lasrado S. Lassi Z.S. Lauriola P. Lawrence W.R. Laxmaiah A. LeGrand K.E. Li M-C. Li B. Li S. Lim S.S. Lim L-L. Lin H. Lin Z. Lin R-T. Liu X. Lopez A.D. Lorkowski S. Lotufo P.A. Lugo A. M N.K. Madotto F. Mahmoudi M. Majeed A. Malekzadeh R. Malik A.A. Mamun A.A. Manafi N. Mansournia M.A. Mantovani L.G. Martini S. Mathur M.R. Mazzaglia G. Mehata S. Mehndiratta M.M. Meier T. Menezes R.G. Meretoja A. Mestrovic T. Miazgowski B. Miazgowski T. Michalek I.M. Miller T.R. Mirrakhimov E.M. Mirzaei H. Moazen B. Moghadaszadeh M. Mohammad Y. Mohammad D.K. Mohammed S. Mohammed M.A. Mokhayeri Y. Molokhia M. Montasir A.A. Moradi G. Moradzadeh R. Moraga P. Morawska L. Moreno Velásquez I. Morze J. Mubarik S. Muruet W. Musa K.I. Nagarajan A.J. Nalini M. Nangia V. Naqvi A.A. Narasimha Swamy S. Nascimento B.R. Nayak V.C. Nazari J. Nazarzadeh M. Negoi R.I. Neupane Kandel S. Nguyen H.L.T. Nixon M.R. Norrving B. Noubiap J.J. Nouthe B.E. Nowak C. Odukoya O.O. Ogbo F.A. Olagunju A.T. Orru H. Ortiz A. Ostroff S.M. Padubidri J.R. Palladino R. Pana A. Panda-Jonas S. Parekh U. Park E-C. Parvizi M. Pashazadeh Kan F. Patel U.K. Pathak M. Paudel R. Pepito V.C.F. Perianayagam A. Perico N. Pham H.Q. Pilgrim T. Piradov M.A. Pishgar F. Podder V. Polibin R.V. Pourshams A. Pribadi D.R.A. Rabiee N. Rabiee M. Radfar A. Rafiei A. Rahim F. Rahimi-Movaghar V. Ur Rahman M.H. Rahman M.A. Rahmani A.M. Rakovac I. Ram P. Ramalingam S. Rana J. Ranasinghe P. Rao S.J. Rathi P. Rawal L. Rawasia W.F. Rawassizadeh R. Remuzzi G. Renzaho A.M.N. Rezapour A. Riahi S.M. Roberts-Thomson R.L. Roever L. Rohloff P. Romoli M. Roshandel G. Rwegerera G.M. Saadatagah S. Saber-Ayad M.M. Sabour S. Sacco S. Sadeghi M. Saeedi Moghaddam S. Safari S. Sahebkar A. Salehi S. Salimzadeh H. Samaei M. Samy A.M. Santos I.S. Santric-Milicevic M.M. Sarrafzadegan N. Sarveazad A. Sathish T. Sawhney M. Saylan M. Schmidt M.I. Schutte A.E. Senthilkumaran S. Sepanlou S.G. Sha F. Shahabi S. Shahid I. Shaikh M.A. Shamali M. Shamsizadeh M. Shawon M.S.R. Sheikh A. Shigematsu M. Shin M-J. Shin J.I. Shiri R. Shiue I. Shuval K. Siabani S. Siddiqi T.J. Silva D.A.S. Singh J.A. Mtech A.S. Skryabin V.Y. Skryabina A.A. Soheili A. Spurlock E.E. Stockfelt L. Stortecky S. Stranges S. Suliankatchi Abdulkader R. Tadbiri H. Tadesse E.G. Tadesse D.B. Tajdini M. Tariqujjaman M. Teklehaimanot B.F. Temsah M-H. Tesema A.K. Thakur B. Thankappan K.R. Thapar R. Thrift A.G. Timalsina B. Tonelli M. Touvier M. Tovani-Palone M.R. Tripathi A. Tripathy J.P. Truelsen T.C. Tsegay G.M. Tsegaye G.W. Tsilimparis N. Tusa B.S. Tyrovolas S. Umapathi K.K. Unim B. Unnikrishnan B. Usman M.S. Vaduganathan M. Valdez P.R. Vasankari T.J. Velazquez D.Z. Venketasubramanian N. Vu G.T. Vujcic I.S. Waheed Y. Wang Y. Wang F. Wei J. Weintraub R.G. Weldemariam A.H. Westerman R. Winkler A.S. Wiysonge C.S. Wolfe C.D.A. Wubishet B.L. Xu G. Yadollahpour A. Yamagishi K. Yan L.L. Yandrapalli S. Yano Y. Yatsuya H. Yeheyis T.Y. Yeshaw Y. Yilgwan C.S. Yonemoto N. Yu C. Yusefzadeh H. Zachariah G. Zaman S.B. Zaman M.S. Zamanian M. Zand R. Zandifar A. Zarghi A. Zastrozhin M.S. Zastrozhina A. Zhang Z-J. Zhang Y. Zhang W. Zhong C. Zou Z. Zuniga Y.M.H. Murray C.J.L. Fuster V. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. J. Am. Coll. Cardiol. 2020 76 25 2982 3021 10.1016/j.jacc.2020.11.010 33309175
    [Google Scholar]
  22. Debreceni B. Debreceni L. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease. Cardiovasc. Ther. 2014 32 3 130 138 10.1111/1755‑5922.12064 24571382
    [Google Scholar]
  23. Rimm E.B. Willett W.C. Hu F.B. Sampson L. Colditz G.A. Manson J.E. Hennekens C. Stampfer M.J. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998 279 5 359 364 10.1001/jama.279.5.359 9459468
    [Google Scholar]
  24. Kaye A.D. Jeha G.M. Pham A.D. Fuller M.C. Lerner Z.I. Sibley G.T. Cornett E.M. Urits I. Viswanath O. Kevil C.G. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels. Adv. Ther. 2020 37 10 4149 4164 10.1007/s12325‑020‑01474‑z 32845472
    [Google Scholar]
  25. Balogh E. Bereczky Z. Katona É. Kőszegi Z. Édes I. Muszbek L. Czuriga I. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: A case-control study. Thromb. Res. 2012 129 2 133 138 10.1016/j.thromres.2011.07.001 21803402
    [Google Scholar]
  26. Balint B. Jepchumba V.K. Guéant J.L. Guéant-Rodriguez R.M. Author Proofs “For Personal Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall. Biochimie 2020 173 100 106 10.1016/j.biochi.2020.02.012 32105811
    [Google Scholar]
  27. Armitage J.M. Bowman L. Clarke R.J. Wallendszus K. Bulbulia R. Rahimi K. Haynes R. Parish S. Sleight P. Peto R. Collins R. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010 303 24 2486 2494 10.1001/jama.2010.840 20571015
    [Google Scholar]
  28. Yang Q. He G.W. Imbalance of Homocysteine and H 2 S: Significance, Mechanisms, and Therapeutic Promise in Vascular Injury. Oxid. Med. Cell. Longev. 2019 2019 1 11 10.1155/2019/7629673 31885816
    [Google Scholar]
  29. Yuan S. Mason A.M. Carter P. Burgess S. Larsson S.C. Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study. BMC Med. 2021 19 1 97 10.1186/s12916‑021‑01977‑8 33888102
    [Google Scholar]
  30. Menotti A. Puddu P.E. Can we still learn from the Seven Countries Study? Curr. Opin. Lipidol. 2018 29 4 313 317 10.1097/MOL.0000000000000520 29708924
    [Google Scholar]
  31. Desai C.K. Huang J. Lokhandwala A. Fernandez A. Riaz I.B. Alpert J.S. The role of vitamin supplementation in the prevention of cardiovascular disease events. Clin. Cardiol. 2014 37 9 576 581 10.1002/clc.22299 24863141
    [Google Scholar]
  32. Hoey L. McNulty H. Askin N. Dunne A. Ward M. Pentieva K. Strain J.J. Molloy A.M. Flynn C.A. Scott J.M. Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am. J. Clin. Nutr. 2007 86 5 1405 1413 10.1093/ajcn/86.5.1405 17991653
    [Google Scholar]
  33. Feng Y. Kang K. Xue Q. Chen Y. Wang W. Cao J. Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension. Medicine (Baltimore) 2020 99 34 e21541 10.1097/MD.0000000000021541 32846763
    [Google Scholar]
  34. Fitzpatrick A.L. Kronmal R.A. Kimura M. Gardner J.P. Psaty B.M. Jenny N.S. Tracy R.P. Hardikar S. Aviv A. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J. Gerontol. A Biol. Sci. Med. Sci. 2011 66A 4 421 429 10.1093/gerona/glq224 21289018
    [Google Scholar]
  35. Hankey G.J. Eikelboom J.W. Homocysteine and vascular disease. Lancet 1999 354 9176 407 413 10.1016/S0140‑6736(98)11058‑9 10437885
    [Google Scholar]
  36. Pusceddu I. Herrmann W. Kleber M.E. Scharnagl H. Hoffmann M.M. Winklhofer-Roob B.M. März W. Herrmann M. Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. Eur. J. Nutr. 2020 59 4 1399 1411 10.1007/s00394‑019‑01993‑8 31129702
    [Google Scholar]
  37. McCully K.S. Homocysteine and vascular disease. Nat. Med. 1996 2 4 386 389 10.1038/nm0496‑386 8597939
    [Google Scholar]
  38. Kromhout D. Menotti A. Alberti-Fidanza A. Puddu P.E. Hollman P. Kafatos A. Tolonen H. Adachi H. Jacobs D.R. Jr Comparative ecologic relationships of saturated fat, sucrose, food groups, and a Mediterranean food pattern score to 50-year coronary heart disease mortality rates among 16 cohorts of the Seven Countries Study. Eur. J. Clin. Nutr. 2018 72 8 1103 1110 10.1038/s41430‑018‑0183‑1 29769748
    [Google Scholar]
  39. Malinow M.R. Duell P.B. Hess D.L. Anderson P.H. Kruger W.D. Phillipson B.E. Gluckman R.A. Block P.C. Upson B.M. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N. Engl. J. Med. 1998 338 15 1009 1015 10.1056/NEJM199804093381501 9535664
    [Google Scholar]
  40. Research on the health of the population of Serbia in 2019. 2020 Available from: https://www-stat-gov-rs.translate.goog/sr-latn/vesti/20210429-istrazivanje-zdravlja-stan/?s=1810&_x_tr_sl=sr&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc(accessed on 20-8-2024)
  41. Nutrition and physical activity - experiences, new trends and recommendations. Food. nutrit. 1997 48 1-4 5 14
    [Google Scholar]
  42. Nygård O. Nordrehaug J.E. Refsum H. Ueland P.M. Farstad M. Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 1997 337 4 230 237 10.1056/NEJM199707243370403 9227928
    [Google Scholar]
  43. Malinow M.R. Bostom A.G. Krauss R.M. Homocysteine, diet and cardiovascular diseases. Circulation 1999 99 1 178 182 10.1161/01.CIR.99.1.178 9884399
    [Google Scholar]
  44. Wang D.D. Li Y. Bhupathiraju S.N. Rosner B.A. Sun Q. Giovannucci E.L. Rimm E.B. Manson J.E. Willett W.C. Stampfer M.J. Hu F.B. Fruit and Vegetable Intake and Mortality. Circulation 2021 143 17 1642 1654 10.1161/CIRCULATIONAHA.120.048996 33641343
    [Google Scholar]
  45. McCully K.S. Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clin. Chem. Lab. Med. 2005 43 10 980 986 10.1515/CCLM.2005.172 16197285
    [Google Scholar]
  46. La Verde M. Mulè S. Zappalà G. Privitera G. Maugeri G. Pecora F. Marranzano M. Higher adherence to the Mediterranean diet is inversely associated with having hypertension: is low salt intake a mediating factor? Int. J. Food Sci. Nutr. 2018 69 2 235 244 10.1080/09637486.2017.1350941 28705075
    [Google Scholar]
  47. Menotti A. Puddu P.E. Lanti M. Maiani G. Catasta G. Alberti Fidanza A. Lifestyle habits and mortality from all and specific causes of death: 40-year follow-up in the Italian Rural Areas of the Seven Countries Study. J. Nutr. Health Aging 2014 18 3 314 321 10.1007/s12603‑013‑0392‑1 24626761
    [Google Scholar]
  48. Welsh G.N. Loscalzo J. Homocystein and aterothrombosis. N. Engl. J. Med. 1998 338 1942 1950
    [Google Scholar]
  49. Arina C. Amir D. Siregar Y. Correlation between homocysteine and dyslipidemia in ishaemic stroke patients with and without Hypertension. Earth. Environ. Sci. 2018 130 012005 10.1088/1755‑1315/130/1/012005
    [Google Scholar]
  50. Schnyder G. Roffi M. Pin R. Flammer Y. Lange H. Eberli F.R. Meier B. Turi Z.G. Hess O.M. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 2001 345 22 1593 1600 10.1056/NEJMoa011364 11757505
    [Google Scholar]
  51. Menotti A. Puddu P.E. How the Seven Countries Study contributed to the definition and development of the Mediterranean diet concept: A 50-year journey. Nutrit. Metab. Cardiovascul. Dis. 2015 25 3 245 252
    [Google Scholar]
  52. Sadeghian S. Fallahi F. Salarifar M. Davoodi G. Mahmoodian M. Fallah N. Darvish S. Karimi A. Tehran Heart Center Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc. Disord. 2006 6 1 38 10.1186/1471‑2261‑6‑38 17002799
    [Google Scholar]
  53. Grundy S.M. Pasternak R. Greenland P. Smith S. Jr Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. J. Am. Coll. Cardiol. 1999 34 4 1348 1359 10.1016/S0735‑1097(99)00387‑3 10520820
    [Google Scholar]
  54. Martí-Carvajal A.J. Solà I. Lathyris D. Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst. Rev. 2017 8 8 CD006612 28816346
    [Google Scholar]
  55. Perk J. De Backer G. Gohlke H. Graham I. Reiner Z. Verschuren M. Albus C. Benlian P. Boysen G. Cifkova R. Deaton C. Ebrahim S. Fisher M. Germano G. Hobbs R. Hoes A. Karadeniz S. Mezzani A. Prescott E. Ryden L. Scherer M. Syvänne M. Scholte Op Reimer W.J.M. Vrints C. Wood D. Zamorano J.L. Zannad F. Cooney M.T. Bax J. Baumgartner H. Ceconi C. Dean V. Deaton C. Fagard R. Funck-Brentano C. Hasdai D. Hoes A. Kirchhof P. Knuuti J. Kolh P. McDonagh T. Moulin C. Popescu B.A. Reiner Z. Sechtem U. Sirnes P.A. Tendera M. Torbicki A. Vahanian A. Windecker S. Funck-Brentano C. Sirnes P.A. Aboyans V. Ezquerra E.A. Baigent C. Brotons C. Burell G. Ceriello A. De Sutter J. Deckers J. Del Prato S. Diener H-C. Fitzsimons D. Fras Z. Hambrecht R. Jankowski P. Keil U. Kirby M. Larsen M.L. Mancia G. Manolis A.J. McMurray J. Pajak A. Parkhomenko A. Rallidis L. Rigo F. Rocha E. Ruilope L.M. van der Velde E. Vanuzzo D. Viigimaa M. Volpe M. Wiklund O. Wolpert C. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2012 33 13 1635 1701 10.1093/eurheartj/ehs092 22555213
    [Google Scholar]
  56. Hong X. Ward P. Woodman R. Is homocysteine an independent predictor of hypertension? A case-control study in an eldery population. Int. J. Clin. Exp. Med. 2017 10 4 7129 7136
    [Google Scholar]
  57. Rodrigo R. Passalacqua W. Araya J. Orellana M. Rivera G. Homocysteine and essential hypertension. J. Clin. Pharmacol. 2003 43 12 1299 1306 10.1177/0091270003258190 14615465
    [Google Scholar]
  58. Sun P. Wang Q. Zhang Y. Association between homocysteine level and blood pressure trait among Tibetans. A cross–section study in China. Medicine 2019 98 27 e16085
    [Google Scholar]
  59. McMahon J.A. Skeaff C.M. Williams S.M. Green T.J. Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J. Nutr. 2007 137 5 1183 1187 10.1093/jn/137.5.1183 17449579
    [Google Scholar]
  60. Han L. Wu Q. Wang C. Hao Y. Zhao J. Zhang L. Fan R. Liu Y. Li R. Chen Z. Zhang T. Chen S. Ma J. Liu S. Peng X. Duan S. Homocystein, ishaemic stroke and coronary heart disease in hypertensive patients: a population – based prospective cohort study. Stroke 2015 46 7 1777 1786 10.1161/STROKEAHA.115.009111 26038522
    [Google Scholar]
  61. Cenko E. Clinical determinants of ischemic heart disease in Eastern Europe. Lancet 2023 33 100698
    [Google Scholar]
  62. Finkelstein J.D. Martin J.J. Homocysteine. Int. J. Biochem. Cell Biol. 2000 32 4 385 389 10.1016/S1357‑2725(99)00138‑7 10762063
    [Google Scholar]
  63. Hermann A. Sitdikova G. Homocysteine: Biochemistry, molecular biology and role in disease. Biomolecules 2021 11 5 737 10.3390/biom11050737 34063494
    [Google Scholar]
  64. Kaplan P. Tatarkova Z. Sivonova M.K. Racay P. Lehotsky J. Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems. Int. J. Mol. Sci. 2020 21 20 7698 10.3390/ijms21207698 33080955
    [Google Scholar]
  65. Hashimoto T. Shinohara Y. Hasegawa H. Homocysteine metabolism. Yakugaku Zasshi 2007 127 10 1579 1592 10.1248/yakushi.127.1579 17917419
    [Google Scholar]
  66. Wijekoon E.P. Brosnan M.E. Brosnan J.T. Homocysteine metabolism in diabetes. Biochem. Soc. Trans. 2007 35 5 1175 1179 10.1042/BST0351175 17956306
    [Google Scholar]
  67. Lu Z.H. Li J. Li X.L. Ding M. Mao C.J. Zhu X.Y. Liu C.F. Hypertension with hyperhomocysteinemia increases the risk of early cognitive impairment after first-ever ischemic stroke. Eur. Neurol. 2019 82 4-6 75 85 10.1159/000504704 31825940
    [Google Scholar]
  68. Burgiadini R. Cenko E. Yoon J. Traditional risk factors and premature acute coronary syndromes in Southeastern Europe: a multinational cohort study. Lancet Reg. Health Eur. 2024 2023 100824 10.1016/j/lanepe
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128326875240916050251
Loading
Homocysteine Blood Levels and Mandatory Folic Acid Fortification in Serbia
Bentham Science Publishers ; https://doi.org/10.2174/0113816128326875240916050251
/content/journals/cpd/10.2174/0113816128326875240916050251
/content/journals/cpd/10.2174/0113816128326875240916050251
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: coronary artery disease ; hypertension ; nutrition ; Homocysteine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test